CompletedNCT00490542
Ziprasidone or placebo for a mixed mood episode in bipolarity
About this title
Read the official source — NCT00490542Medication studyAges 18–65United StatesDepression
Understand this study
Who was this study for?
Listed age limits: 18 years to 65 years.
- Listed locations
- Chicago and 3 more locationsSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Study information
Study start dateDecember 2006
- Recruitment status
- Completed
- Enrollment listed in the registry
- 73
- Sponsor
- Tufts Medical Center
- Sponsor type
- Hospital / academic medical center
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT00490542
- Official title
Show the full official title
Double-blind, Placebo-controlled Trial of Ziprasidone (Geodon) for the Depressive Mixed State
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Chicago · Boston · Cambridge
1 more locations
- Durham
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Tufts Medical Center, a hospital or academic medical center.
Did this study involve medication?
Yes. The study involved medication, including ziprasidone (Geodon) and placebo.
Who was this study for?
Listed age limits: 18 years to 65 years.
